Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication: Correction with fibronectin and factor XIII cross-linking
✍ Scribed by Eduardo Weiss; Yuji Yamaguchi; Anna Falabella; Saara Crane; Yasutaka Tokuda; Vincent Falanga
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 310 KB
- Volume
- 174
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Wound repair is characterized by the presence of a fibrin-rich matrix, but the effect of fibrin on re-epithelialization remains unclear. In this study, we determined the effects of different fibrin matrices on cultured human neonatal keratinocytes. Using purified fibrinogen and fibrin gels generated by the enzymatic action of thrombin, batroxobin (it leads to retention of fibrinopeptide B), or Agkistrodon contortrix thrombin-like enzyme (ACTE; it leads to retention of fibrinopeptide A), we determined the effect of each of these matrices on keratinocyte morphology, attachment, spreading, and replication as compared to tissue culture plastic. Morphologically, keratinocytes seeded on fibrin surfaces were more rounded and formed three-dimensional structures. Specific cell attachment, as measured at either 37ЊC or 4ЊC, was not altered on the different fibrin substrates (P ú .05) but was increased on fibrinogen and factor XIII cross-linked fibrin (P õ .01). However, keratinocytes seeded on fibrin, regardless of the presence or absence of fibrinopeptides A or B, showed a marked decrease (up to 71%) in cell numbers by days 5 (P Å .0357) and 10 (P Å .0114). Keratinocyte spreading was decreased by 78.8% (P Å .0006), 80.3% (P Å .0001), and 89.2% (P Å .0001) on thrombin-, batroxobin-, and ACTE-generated fibrin, respectively, but not on fibrinogencoated dishes. However, either the addition of fibronectin or cross-linking of fibrin with factor XIII allowed full keratinocyte spreading to occur (P Å .0002 and P Å .0013, respectively). We conclude that fibrin inhibits keratinocyte spreading in the absence of other matrix or plasma proteins or cross-linking by factor XIII.